Antibodies against HER2 truncated variant CTF-611
The present invention relates to a method of diagnosis and therapy of cancers expressing the HER2 receptor. The invention provides antibodies or fragments thereof that recognise an epitope of the HER2 receptor truncated form CTF-61 1, said epitope being defined by a sequence included in SEQ ID NO: 2...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ARRIBAS LÓPEZ, JOAQUÍN PARRA PALAU, JOSEP LLUÍS BASELGA TORRES, JOSÉ ANGELLINI, PIER-DAVIDE PEDERSEN, KIM |
| description | The present invention relates to a method of diagnosis and therapy of cancers expressing the HER2 receptor. The invention provides antibodies or fragments thereof that recognise an epitope of the HER2 receptor truncated form CTF-61 1, said epitope being defined by a sequence included in SEQ ID NO: 2, and that are capable of discriminating between CTF-611 and CTF-616 (represented by SEQ ID NO:7), preferably additionally capable of discriminating between CTF-611 and CTF-613 (represented by SEQ ID NO:6) . The invention also provides a method of cancer diagnosis using the disclosed antibodies, which comprises the detection of the presence of the HER2 receptor truncated form consisting of the amino acid sequence SEQ ID NO: 1 in a patient sample. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2360187B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2360187B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2360187B13</originalsourceid><addsrcrecordid>eNrjZDB0zCvJTMpPyUwtVkhMT8zMKy5R8HANMlIoKSrNS04sSU1RKEssykzMK1FwDnHTNTM05GFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BRsZmBoYW5k6GxkQoAQCooCmz</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Antibodies against HER2 truncated variant CTF-611</title><source>esp@cenet</source><creator>ARRIBAS LÓPEZ, JOAQUÍN ; PARRA PALAU, JOSEP LLUÍS ; BASELGA TORRES, JOSÉ ; ANGELLINI, PIER-DAVIDE ; PEDERSEN, KIM</creator><creatorcontrib>ARRIBAS LÓPEZ, JOAQUÍN ; PARRA PALAU, JOSEP LLUÍS ; BASELGA TORRES, JOSÉ ; ANGELLINI, PIER-DAVIDE ; PEDERSEN, KIM</creatorcontrib><description>The present invention relates to a method of diagnosis and therapy of cancers expressing the HER2 receptor. The invention provides antibodies or fragments thereof that recognise an epitope of the HER2 receptor truncated form CTF-61 1, said epitope being defined by a sequence included in SEQ ID NO: 2, and that are capable of discriminating between CTF-611 and CTF-616 (represented by SEQ ID NO:7), preferably additionally capable of discriminating between CTF-611 and CTF-613 (represented by SEQ ID NO:6) . The invention also provides a method of cancer diagnosis using the disclosed antibodies, which comprises the detection of the presence of the HER2 receptor truncated form consisting of the amino acid sequence SEQ ID NO: 1 in a patient sample.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; TESTING</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160420&DB=EPODOC&CC=EP&NR=2360187B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160420&DB=EPODOC&CC=EP&NR=2360187B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ARRIBAS LÓPEZ, JOAQUÍN</creatorcontrib><creatorcontrib>PARRA PALAU, JOSEP LLUÍS</creatorcontrib><creatorcontrib>BASELGA TORRES, JOSÉ</creatorcontrib><creatorcontrib>ANGELLINI, PIER-DAVIDE</creatorcontrib><creatorcontrib>PEDERSEN, KIM</creatorcontrib><title>Antibodies against HER2 truncated variant CTF-611</title><description>The present invention relates to a method of diagnosis and therapy of cancers expressing the HER2 receptor. The invention provides antibodies or fragments thereof that recognise an epitope of the HER2 receptor truncated form CTF-61 1, said epitope being defined by a sequence included in SEQ ID NO: 2, and that are capable of discriminating between CTF-611 and CTF-616 (represented by SEQ ID NO:7), preferably additionally capable of discriminating between CTF-611 and CTF-613 (represented by SEQ ID NO:6) . The invention also provides a method of cancer diagnosis using the disclosed antibodies, which comprises the detection of the presence of the HER2 receptor truncated form consisting of the amino acid sequence SEQ ID NO: 1 in a patient sample.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB0zCvJTMpPyUwtVkhMT8zMKy5R8HANMlIoKSrNS04sSU1RKEssykzMK1FwDnHTNTM05GFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BRsZmBoYW5k6GxkQoAQCooCmz</recordid><startdate>20160420</startdate><enddate>20160420</enddate><creator>ARRIBAS LÓPEZ, JOAQUÍN</creator><creator>PARRA PALAU, JOSEP LLUÍS</creator><creator>BASELGA TORRES, JOSÉ</creator><creator>ANGELLINI, PIER-DAVIDE</creator><creator>PEDERSEN, KIM</creator><scope>EVB</scope></search><sort><creationdate>20160420</creationdate><title>Antibodies against HER2 truncated variant CTF-611</title><author>ARRIBAS LÓPEZ, JOAQUÍN ; PARRA PALAU, JOSEP LLUÍS ; BASELGA TORRES, JOSÉ ; ANGELLINI, PIER-DAVIDE ; PEDERSEN, KIM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2360187B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>ARRIBAS LÓPEZ, JOAQUÍN</creatorcontrib><creatorcontrib>PARRA PALAU, JOSEP LLUÍS</creatorcontrib><creatorcontrib>BASELGA TORRES, JOSÉ</creatorcontrib><creatorcontrib>ANGELLINI, PIER-DAVIDE</creatorcontrib><creatorcontrib>PEDERSEN, KIM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ARRIBAS LÓPEZ, JOAQUÍN</au><au>PARRA PALAU, JOSEP LLUÍS</au><au>BASELGA TORRES, JOSÉ</au><au>ANGELLINI, PIER-DAVIDE</au><au>PEDERSEN, KIM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Antibodies against HER2 truncated variant CTF-611</title><date>2016-04-20</date><risdate>2016</risdate><abstract>The present invention relates to a method of diagnosis and therapy of cancers expressing the HER2 receptor. The invention provides antibodies or fragments thereof that recognise an epitope of the HER2 receptor truncated form CTF-61 1, said epitope being defined by a sequence included in SEQ ID NO: 2, and that are capable of discriminating between CTF-611 and CTF-616 (represented by SEQ ID NO:7), preferably additionally capable of discriminating between CTF-611 and CTF-613 (represented by SEQ ID NO:6) . The invention also provides a method of cancer diagnosis using the disclosed antibodies, which comprises the detection of the presence of the HER2 receptor truncated form consisting of the amino acid sequence SEQ ID NO: 1 in a patient sample.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP2360187B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING |
| title | Antibodies against HER2 truncated variant CTF-611 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T17%3A15%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ARRIBAS%20L%C3%93PEZ,%20JOAQU%C3%8DN&rft.date=2016-04-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2360187B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |